Award
Baltimore VA Medical Center 11357985
Enhancing FLT3 inhibitor efficacy in acute myeloid leukemia with FLT3-ITD
Recipient
Baltimore VA Medical Center
Awarded
August 06, 2026
Identifier
11357985
Award for clinical research aimed at improving treatment efficacy for acute myeloid leukemia patients with FLT3-ITD by exploring signaling pathways, resistance mechanisms, and combination therapies.
Description
This project focuses on developing clinical trials to improve outcomes for patients with AML with FLT3-ITD, a subtype associated with poor prognosis. The research involves targeting signaling pathways, resistance mechanisms, and combination therapies to enhance treatment efficacy.